References
- Luntz M, Levit I, Sade J. The histological patterns of normal and inflamed middle ear mucosa. Eur Arch Otorhinolaryngol 1991;248:127–8.
- Tanaka K, Saito J, Ohashi M, Terayama Y. Histopathology of otitis media with effusion. An electron microscopic study of human temporal bones. Arch Otorhinolaryngol 1986;243:269–73.
- Yellon RF, Leonard G, Marucha P, Sidman J, Carpenter R, Burleson J, Demonstration of interleukin 6 in middle ear effusions. Arch Otolaryngol Head Neck Surg 1992;118:745–8.
- Schousboe LP, Ovesen T, Eckhardt L, Rasmussen LM, Pedersen CB. How does endotoxin trigger inflammation in otitis media with effusion? Laryngoscope 2001;111:297–300.
- Widemar L, Hellström S, Schultzberg U, Stenfors LE. Autonomic innervation of the tympanic membrane. An immunocytochemical and histofluorescence study. Acta Otolaryngol 1985;100:58–65.
- Basak S, Dikicioglu E, Turkutanit S, Sarierler M. Early and late effects of capsaicin pretreatment in otitis media with effusion. Otol Neurotol 2005;26:344–50.
- Erin N, Ersoy Y, Ercan F, Akici A, Oktay S. NK-1 antagonist CP99994 inhibits stress-induced mast cell degranulation in rats. Clin Exp Dermatol 2004;29:644–8.
- Szema AM, Hamidi SA, Lyubsky S, Dickman KG, Mathew S, Abdel-Razek T, Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am J Physiol Lung Cell Mol Physiol 2006;291:L880–6.
- Carrie S, Hutton DA, Birchall JP, Green GG, Pearson JP. Otitis media with effusion: components which contribute to the viscous properties. Acta Otolaryngol 1992;112:504–11.
- Herbert G, Weber A, Röder S, Elvers HD, Kramer U, Schins RP, Relation between stressful life events, neuropeptides and cytokines: results from the LISA birth cohort study. Pediatr Allergy Immunol 2008;19:722–9.
- Uddman R, Luts A, Sundler F. Occurrence and distribution of calcitonin gene-related peptide in the mammalian respiratory tract and middle ear. Cell Tissue Res 1985;241:551–5.
- Hellström S, Goldie P. Mechanisms of otitis media development: involvement of neurogenic inflammation. Otolaryngol Clin North Am 1991;24:829–34.
- Cayé-Thomasen P, Schmidt PT, Hermansson A, Holst JJ, Thomsen J. Depletion of mucosal substance P in acute otitis media. Acta Otolaryngol 2004;124:794–7.
- Wang G. Study on the correlation of substance P in middle ear effusion and clinical presentation in secretory otitis media. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005;19:1026–8.
- Goldie P, Hellström S, Idahl LA. Middle ear effusion induced by various inflammatory mediators and neuropeptides. An experimental study in the rat. Acta Otolaryngol 1989;108:246–52.
- Basak S, Turkutanit S, Sarierler M, Metin KK. Effects of capsaicin pre-treatment in experimentally-induced secretory otitis media. J Laryngol Otol 1999;113:114–17.
- Onoue S, Yamada S, Yajima T. Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD. Peptides 2007;28:1640–50.
- Nyman MJ, Eskola O, Kajander J, Vahlberg T, Sanabria S, Burns D, Gender and age affect NK1 receptors in the human brain – a positron emission tomography study with [18F]SPA-RQ. Int J Neuropsychopharmacol 2007;10:219–29.
- Mohammed H, Hannibal J, Fahrenkrug J, Santer R. Distribution and regional variation of pituitary adenylate cyclase activating polypeptide and other neuropeptides in the rat urinary bladder and ureter: effects of age. Urol Res 2002;30:248–55.
- Groneberg DA, Rabe KF, Fischer A. Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors. Eur J Pharmacol 2006;533:182–94.